These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33165141)

  • 1. Role of Hydrogen Sulfide in Myocardial Ischemia-Reperfusion Injury.
    Zhang P; Yu Y; Wang P; Shen H; Ling X; Xue X; Yang Q; Zhang Y; Xiao J; Wang Z
    J Cardiovasc Pharmacol; 2021 Feb; 77(2):130-141. PubMed ID: 33165141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury.
    Citi V; Piragine E; Testai L; Breschi MC; Calderone V; Martelli A
    Curr Med Chem; 2018; 25(34):4380-4401. PubMed ID: 29436990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
    Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
    Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do nitric oxide, carbon monoxide and hydrogen sulfide really qualify as 'gasotransmitters' in bacteria?
    Wareham LK; Southam HM; Poole RK
    Biochem Soc Trans; 2018 Oct; 46(5):1107-1118. PubMed ID: 30190328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
    Polhemus DJ; Lefer DJ
    Circ Res; 2014 Feb; 114(4):730-7. PubMed ID: 24526678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gasotransmitters: growing pains and joys.
    Wang R
    Trends Biochem Sci; 2014 May; 39(5):227-32. PubMed ID: 24767680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effects of hydrogen sulfide in attenuating myocardial ischemia‑reperfusion injury (Review).
    Wu D; Gu Y; Zhu D
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34726247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
    Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
    Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
    Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the protective role of hydrogen sulfide in myocardial ischemia/reperfusion injury: a narrative review.
    Zhang ML; Peng W; Ni JQ; Chen G
    Med Gas Res; 2021; 11(2):83-87. PubMed ID: 33818448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies.
    Pagliaro P; Weber NC; Femminò S; Alloatti G; Penna C
    Basic Res Cardiol; 2024 Aug; 119(4):509-544. PubMed ID: 38878210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in rats.
    Sun YG; Wang XY; Chen X; Shen CX; Li YG
    Int J Clin Exp Pathol; 2015; 8(1):474-81. PubMed ID: 25755736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis and the Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches to Disease Prevention.
    Wang ZJ; Wu J; Guo W; Zhu YZ
    Cell Physiol Biochem; 2017; 42(3):859-875. PubMed ID: 28641276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review).
    Dongó E; Hornyák I; Benko Z; Kiss L
    Acta Physiol Hung; 2011 Dec; 98(4):369-81. PubMed ID: 22173019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System.
    Nagpure BV; Bian JS
    Oxid Med Cell Longev; 2016; 2016():6904327. PubMed ID: 26640616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities.
    Papapetropoulos A; Foresti R; Ferdinandy P
    Br J Pharmacol; 2015 Mar; 172(6):1395-6. PubMed ID: 25891246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular Mechanisms of Action of Gas Transmitters NO, CO and H2S in Smooth Muscle Cells and Effect of NO-generating Compounds (Nitrates and Nitrites) on Average Life Expectancy].
    Gusakova SV; Smagliy LV; Birulina YG; Kovalev IV; Nosarev V; Petrova IV; Reutov VP
    Usp Fiziol Nauk; 2017; 48(1):24-52. PubMed ID: 29283238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction.
    Payne FM; Dabb AR; Harrison JC; Sammut IA
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen Sulfide Biochemistry and Interplay with Other Gaseous Mediators in Mammalian Physiology.
    Giuffrè A; Vicente JB
    Oxid Med Cell Longev; 2018; 2018():6290931. PubMed ID: 30050658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.